Skip to content

Topic

Parkinson's disease

Degenerative neurological disorder marked by tremor, slowed movement and changes to speech, caused by the loss of dopamine-producing neurons in the brain.

Current stories

scienceOne report1 publisher

Hollow silica nanostructures let low-intensity ultrasound stimulate mouse brains for over nine weeks

Hong Kong Polytechnic University team reports hollow silica nanostructures that kept responding to ultrasound in mouse brains for over nine weeks. Earlier nanoparticle approaches lacked that durability. The evidence so far comes from mice.

Publishers:phys.org

Reality

Evidence45
Adoption
Not scored
Hype gap+20
Incentives
Not scored
Confidence50
scienceOne report1 publisher

Microglia in a dish need the Parkinson's risk protein GPNMB to nibble toxic clumps off living neurons

Oxford researchers report human microglia nibble alpha-synuclein clumps off living dopamine neurons in stem-cell cultures, a process that needs GPNMB. A gene flagged by genome-wide studies now has a testable role in the brain's immune cells, though so far only in a dish.

Reality

Evidence35
Adoption
Not scored
Hype gap+40
Incentives55
Confidence40
scienceOne report1 publisher

Brain-stimulation timing decides cognition for GBA1 Parkinson's patients

Deep brain stimulation within 7 to 8 years of diagnosis preserved cognition in Parkinson's patients with a GBA1 mutation, a 10-center study of 343 found. The timing effect appeared only in carriers, pointing clinicians toward testing for the mutation before deciding when to operate.

Reality

Evidence40
Adoption
Not scored
Hype gap+45
Incentives55
Confidence35
scienceOne report1 publisher

Scans of 24 long COVID patients tie slowed movement and low motivation to depleted dopamine nerve endings

Canadian researchers scanning 24 people with long COVID found fewer dopamine nerve endings in the striatum, a shortfall tied to a quarter of symptom variance. The result gives drug trials a dopamine hypothesis to test, though the scan reads a protein marker that stands in for the neurons themselves.

Publishers:sciencealert.com

Reality

Evidence40
Adoption
Not scored
Hype gap+30
Incentives55
Confidence45
scienceOne report1 publisher

Two RAB1 proteins bridge the adaptor OPTN to the vesicles that seed mitophagy membranes

Tokyo Metropolitan Institute of Medical Science researchers report that RAB1A and RAB1B, two of about 60 human RAB proteins, tie OPTN to ATG9A vesicles. The link helps set where the membrane around a damaged mitochondrion begins to form, and labs can now test that step directly.

Publishers:phys.org

Reality

Evidence45
Adoption
Not scored
Hype gap+10
Incentives
Not scored
Confidence55
scienceOne report1 publisher

Belly button and nose odors differed by disease in a 24-person Fraunhofer pilot

Fraunhofer IIS researchers found swab odors from 24 people differed between healthy volunteers and those with Parkinson's, cognitive impairment or COVID-19. The team calls it a proof of concept, and a needle-free test would first have to hold up in larger, age-matched groups outside the lab.

Reality

Evidence35
Adoption
Not scored
Hype gap+10
Incentives
Not scored
Confidence40
scienceConfirmed2 publishers

A regenerating flatworm neuron gets its transmitter and its position from six of ten identified genes

University of Georgia researchers report the ten genes in Nature Communications and characterized six of them in detail. Knocking some of them out left planarians unable to make new dopamine neurons and slow to move.

Perspective Coverage

3 publishers
Builder
Builder 47%
Operator
Operator 35%
Investor
Investor 18%

Reality

Evidence66
Adoption
Not scored
Hype gap+24
Incentives58
Confidence62
scienceOne report1 publisher

Ariadne Bio aims a non-hallucinogenic 5-HT2A agonist at Parkinson's apathy

Palomar Labs' first spinout is built on a molecule whose parent compound was tested in the 1970s and documented not to be hallucinogenic. Apathy affects about 40% of people with Parkinson's, and no drug is approved for it.

Publishers:genengnews.com

Reality

Evidence40
Adoption8
Hype gap+35
Incentives82
Confidence42
productOne report1 publisher

Journal of Voice study ties voice-disorder diagnoses to 58 percent higher dementia risk

The paper counted diagnoses clinicians wrote for patients aged 50 and over, and the risk more than doubled when hearing loss came with the voice disorder. Voice software was never in the study.

Publishers:dexerto.com

Reality

Evidence55
Adoption
Not scored
Hype gap+25
Incentives40
Confidence50